Trial Details
COMPLETEDBasic Information
| Clinical ID | c1409 |
|---|---|
| Identifier | NCT04924114 |
| Trial Title | A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: MK-6194|DRUG: MK-6194-matching placebo |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | Rialto |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2021-10-14 |
|---|---|
| Primary Completion Date | 2024-01-08 |
| Completion Date | 2024-07-15 |